BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4015705)

  • 1. Studies on the mechanism of action of quinone antitumor agents.
    Begleiter A
    Biochem Pharmacol; 1985 Aug; 34(15):2629-36. PubMed ID: 4015705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
    Begleiter A; Blair GW
    Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of alkylation to the activity of quinone antitumor agents.
    Begleiter A
    Can J Physiol Pharmacol; 1986 May; 64(5):581-5. PubMed ID: 3730943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of quinone alkylating agents in quinone-resistant cells.
    Begleiter A; Leith MK
    Cancer Res; 1990 May; 50(10):2872-6. PubMed ID: 1692249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytocidal action of the quinone group and its relationship to antitumor activity.
    Begleiter A
    Cancer Res; 1983 Feb; 43(2):481-4. PubMed ID: 6848172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA
    Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
    Begleiter A; Leith MK; Pan SS
    Mol Pharmacol; 1991 Sep; 40(3):454-8. PubMed ID: 1896030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sensitivity of quinone resistant cells to mitomycin C.
    Begleiter A; Robotham E; Lacey G; Leith MK
    Cancer Lett; 1989 Jun; 45(3):173-6. PubMed ID: 2471583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
    Li Y; Kuppusamy P; Zweir JL; Trush MA
    Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.
    Halinska A; Belej T; O'Brien PJ
    Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
    Winski SL; Swann E; Hargreaves RH; Dehn DL; Butler J; Moody CJ; Ross D
    Biochem Pharmacol; 2001 Jun; 61(12):1509-16. PubMed ID: 11377380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive activation of potential antitumor bis(aziridinyl)benzoquinones by xanthine oxidase: competition between oxygen reduction and quinone reduction.
    Lusthof KJ; Richter W; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Arch Biochem Biophys; 1990 Feb; 277(1):137-42. PubMed ID: 2154955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
    Jeong JK; Stevens JL; Lau SS; Monks TJ
    Mol Pharmacol; 1996 Sep; 50(3):592-8. PubMed ID: 8794898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage in L5178YS cells following exposure to benzene metabolites.
    Pellack-Walker P; Blumer JL
    Mol Pharmacol; 1986 Jul; 30(1):42-7. PubMed ID: 3724744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of DNA single- and double-strand breaks by diethylstilbestrol in murine L5178Y lymphoblasts in vitro.
    Goldenberg GJ; Froese EK
    Biochem Pharmacol; 1985 Mar; 34(6):771-6. PubMed ID: 3977954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of quantitative structure-toxicity relationships for the comparison of the cytotoxicity of 14 p-benzoquinone congeners in primary cultured rat hepatocytes versus PC12 cells.
    Siraki AG; Chan TS; O'Brien PJ
    Toxicol Sci; 2004 Sep; 81(1):148-59. PubMed ID: 15178806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.